FindTrial
Sign In

Using n-of-1 trial to evaluate the effect of LiuWei DiHuang capsul in the treatment of patient with TCM sign both Gan and Shen deficiency

Building comprehensive model of evaluation of Traditional Chinese Medicine by n-of-1 trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ION-16008726
Enrollment
Unknown
Registered
2016-06-27
Start date
2016-07-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney Yin deficiency syndrome

Interventions

Treatment Group:LiuWeiDiHuang capsule
Control Group:placebo

Sponsors

ShenZhen TCM hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with TCM sign both Gan and Shen deficiency; aged 25 to 65; education level is above primary school; informed consent.

Exclusion criteria

Exclusion criteria: Acute cardiovascular and cerebrovascular disease patients; with severe digestive, liver, kidney, hematopoietic systemic disease; severe hypertension and blood pressure has not been effectively controlled by; diabetes, poor blood sugar control; pregnant or lactating women; allergies; investigator assess not suitable.

Design outcomes

Primary

MeasureTime frame
Chines sydrome rating;—

Secondary

MeasureTime frame
SF-36;—

Countries

China

Contacts

Public ContactLiu Yu

Shenzhen TCM hospital

401422986@qq.com+86 0577-22664249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026